Nanoco signs new Joint Development Agreement with second Asian chemical customer

Nanoco Group

Nanoco Group plc (LON:NANO), a world leader in the development and manufacture of cadmium-free quantum dots and other specific nanomaterials emanating from its technology platform, has announced it has signed a major new Joint Development Agreement with a new second Asian chemical customer.

The target of the one-year programme is to optimise lead-free nanomaterials to be incorporated into global electronics applications. Once successful, the subsequent stage will involve scale up to industrial production levels during 2027.

The revenue from the JDA will help the Group exceed current expectations for non-license fee income in FY25, and contribute further revenue to FY26.

Dmitry Shashkov, Nanoco’s CEO, commented:

“This JDA with another Asian chemical company highlights the growing focus on the incorporation of quantum dots into sensors for high volume commercial applications.

“The consensus of market research is that quantum dot enabled silicon sensors, especially ones which are lead-free, will disrupt the global consumer electronics market, and Nanoco along with its customers are at the forefront of this technology, and we also have significant IP protections in this area.

“Discussions are ongoing with other potential new customers around further potential projects and we look forward to updating shareholders further in due course.”

Share on:

Latest Company News

Emerging markets gain as oil pressure eases and AI demand supports stocks

Emerging markets are gaining investor attention as lower oil prices and AI-linked demand support stocks, currencies and broader risk appetite.

Biotech Growth Trust outperforms benchmark in April

Biotech Growth Trust’s NAV and share price rose 0.8% in April, outperforming the NASDAQ Biotechnology Index, which fell 2.3%, supported by stock-specific gains and continued biotech M&A activity.

Serco retains £270m facilities management contract at NNUH

Serco has renewed its facilities management contract at Norfolk and Norwich University Hospital, extending integrated service delivery and support for hospital operations over the next 10 years.

CVS Group refinances £350m debt and launches £50m share buyback

CVS has refinanced its £350m bank facilities on improved terms, launched a £50m share buyback and acquired another small animal practice in Australia.

Kingfisher confirms full-year guidance after resilient Q1

Kingfisher said it remains on track to meet full-year guidance after a resilient first quarter, with growth in e-commerce, trade sales and marketplace activity offsetting softer seasonal demand.

Melrose Industries’ GKN Garden Grove MMA tank incident update

Melrose Industries' GKN Aerospace continues to work with emergency services and authorities following a thermal issue involving an MMA storage tank at its Garden Grove facility. Authorities have confirmed reduced evacuation orders and no injuries, leaks or contamination.

    Search